Key Metrics
2.2
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
Q4
Drug Discovery
SJR
- Q3 Drug Discovery
- Q4 Molecular Medicine
- Q3 Pharmaceutical Science
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
0.38
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Indexed in the following public directories
-
Web of Science -
Scopus -
SJR
Topics Covered
- Oxidative stress
- Chalcone
- Inhibitory effect
- Biological evaluation
- Homology modeling
- Mycobacterium tuberculosis
- Molecular dynamics
- Epidermal growth factor receptor
- Pyrazole
- Western blot
- Knowledge base
- Antibacterial activity
- Virtual screening
- Anti-inflammatory
- Drug design
- Pyrimidine
- Mechanism of action
- Cyclooxygenase
- Network pharmacology
- Breast cancer
Journal Specifications
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2004 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Letters in Drug Design and Discovery ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Bioinformatics-based Analysis of the Variability of MPOX Virus Proteins
- 1 Dec 24
- Letters in Drug Design & Discovery
-
Full paper
3D and 2D-QSAR Studies on Natural Flavonoids for Nitric Oxide Production Inhibitory Activity
- 1 Dec 24
- Letters in Drug Design & Discovery
-
Full paper
Development of Potential Antidiabetic Agents using 2D and 3D QSAR, Molecular Docking and ADME Properties In-silico Studies of α-amylase Inhibitors
- 1 Dec 24
- Letters in Drug Design & Discovery
-
Full paper
A Deep Dive into PDE5 Inhibition: Innovative Discoveries via Virtual Screening
- 1 Dec 24
- Letters in Drug Design & Discovery
-
Full paper
Do Anticancer Medicinal Compounds have DNMT1 Regulating Activity: An In silico Investigation
- 1 Dec 24
- Letters in Drug Design & Discovery
-
Full paper
Discovery of the Aminated Quinoxalines as Potential Active Molecules
- 1 Dec 24
- Letters in Drug Design & Discovery
Scite analysis
Powered by scite_
2.9k articles received 7.9k citations see all
- 205 Supporting
- 7,548 Mentioning
- 4 Contrasting
Editorial notices
- 0 Retractions
- 4 Withdrawals
- 1 Corrections
- 0 Errata
- 0 Expression of Concern
FAQs
How long has Letters in Drug Design and Discovery been actively publishing?
Letters in Drug Design and Discovery has been in operation since 2004 till date.
What is the publishing frequency of Letters in Drug Design and Discovery ?
Letters in Drug Design and Discovery published with a Monthly frequency.
How many articles did Letters in Drug Design and Discovery publish last years ?
In 2023, Letters in Drug Design and Discovery published 209 articles.
What is the eISSN & pISSN for Letters in Drug Design and Discovery ?
For Letters in Drug Design and Discovery,eISSN is 1875-628X and pISSN is1570-1808.
What is Citescore for Letters in Drug Design and Discovery ?
Citescore for Letters in Drug Design and Discovery is 2.2.
What is SNIP score for Letters in Drug Design and Discovery ?
SNIP score for Letters in Drug Design and Discovery is 0.38.
What is the SJR for Letters in Drug Design and Discovery ?
SJR for Letters in Drug Design and Discovery is Q4.
Who is the publisher of Letters in Drug Design and Discovery ?
BENTHAM SCIENCE PUBL LTD is the publisher of Letters in Drug Design and Discovery.